GlassScriptPhysician profile
Robert G Snow
NPI 1023067485
$215,674.70
in general payments reported to CMS, 2019-2025
19 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $145 · 2021: $1,477 · 2022: $24K · 2023: $59K · 2024: $57K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $146K · Travel and Lodging: $16K · Consulting Fee: $13K · Education: $12K · Food and Beverage: $4,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $145,875.00 |
| Travel and Lodging | $15,736.23 |
| Consulting Fee | $12,800.00 |
| Education | $11,554.88 |
| Food and Beverage | $4,180.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $159,419.04 | 2023-2025 | Orbera Intragastric Balloon System, General - Therapies, Overstitch Endoscopic Suturing System |
| Apollo Endosurgery US INC | $40,948.00 | 2021-2023 | Overstitch Endoscopic Suturing System |
| Intuitive Surgical, INC. | $12,970.21 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,047.48 | 2024 | Echelon Flex |
| Baxter Healthcare | $229.34 | 2019-2024 | Tisseel |
| Lucid Diagnostics INC. | $181.41 | 2022-2024 | |
| Reshape Lifesciences INC. | $166.70 | 2022 | |
| Levita Magnetics International Corp | $156.84 | 2019 | |
| Ethicon US, LLC | $119.87 | 2022-2024 | Echelon; Endopath, Echelon Endopath, Enseal |
| Novo Nordisk INC | $77.44 | 2019-2023 | Wegovy |
| Olympus Corporation of The Americas | $65.00 | 2023 | Itind System |
| Tela Bio, INC. | $60.30 | 2024 | Ovitex 2s |
| Standard Bariatrics, INC. | $58.50 | 2022 | |
| Lexington Medical, INC. | $50.14 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $35.20 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $35.14 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $20.19 | 2019 | |
| Olympus America INC. | $19.82 | 2020 | |
| Acell, INC. | $14.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Snow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.